111 related articles for article (PubMed ID: 38598629)
1. Elesclomol-copper synergizes with imidazole ketone erastin by promoting cuproptosis and ferroptosis in myelodysplastic syndromes.
Gao Y; Jin F; Zhang P; Zheng C; Zheng X; Xie J; Lu Y; Tong X; Du J; Zhang J; Wang Y
Biomed Pharmacother; 2024 Jun; 175():116727. PubMed ID: 38733771
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy.
Li Y; Liu J; Chen Y; Weichselbaum RR; Lin W
Adv Sci (Weinh); 2024 Jun; 11(23):e2310309. PubMed ID: 38477411
[TBL] [Abstract][Full Text] [Related]
3. Cuproptosis: Mechanism, role, and advances in urological malignancies.
Wu J; He J; Liu Z; Zhu X; Li Z; Chen A; Lu J
Med Res Rev; 2024 Jul; 44(4):1662-1682. PubMed ID: 38299968
[TBL] [Abstract][Full Text] [Related]
4. CuO Nanozymes Catalyze Cysteine and Glutathione Depletion Induced Ferroptosis and Cuproptosis for Synergistic Tumor Therapy.
Bai J; Zhang X; Zhao Z; Sun S; Cheng W; Yu H; Chang X; Wang B
Small; 2024 May; ():e2400326. PubMed ID: 38813723
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis and cuproptosis: Metal-dependent cell death pathways activated in response to classical chemotherapy - Significance for cancer treatment?
Kciuk M; Gielecińska A; Kałuzińska-Kołat Ż; Yahya EB; Kontek R
Biochim Biophys Acta Rev Cancer; 2024 Jul; 1879(4):189124. PubMed ID: 38801962
[TBL] [Abstract][Full Text] [Related]
6. Progress and Challenges in Tumor Ferroptosis Treatment Strategies: A Comprehensive Review of Metal Complexes and Nanomedicine.
Su Y; Liu B; Wang B; Chan L; Xiong C; Lu L; Zhang X; Zhan M; He W
Small; 2024 Jun; 20(25):e2310342. PubMed ID: 38221682
[TBL] [Abstract][Full Text] [Related]
7. Copper homeostasis dysregulation in respiratory diseases: a review of current knowledge.
Song W; Yue Y; Zhang Q; Wang X
Front Physiol; 2024; 15():1243629. PubMed ID: 38883186
[TBL] [Abstract][Full Text] [Related]
8. Editorial: Targeting ion homeostasis for cancer therapy: mechanisms and immunomodulatory effects.
Zeng X; Li Z; Yi Z; Yan S
Front Pharmacol; 2024; 15():1418700. PubMed ID: 38779138
[No Abstract] [Full Text] [Related]
9. Carrier-Free Self-Assembly Nano-Sonosensitizers for Sonodynamic-Amplified Cuproptosis-Ferroptosis in Glioblastoma Therapy.
Zhu Y; Niu X; Ding C; Lin Y; Fang W; Yan L; Cheng J; Zou J; Tian Y; Huang W; Huang W; Pan Y; Wu T; Chen X; Kang D
Adv Sci (Weinh); 2024 Jun; 11(23):e2402516. PubMed ID: 38582500
[TBL] [Abstract][Full Text] [Related]
10. Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death.
Li Y; Du Y; Zhou Y; Chen Q; Luo Z; Ren Y; Chen X; Chen G
Cell Commun Signal; 2023 Nov; 21(1):327. PubMed ID: 37974196
[TBL] [Abstract][Full Text] [Related]
11. Cellular Trojan Horse initiates bimetallic Fe-Cu MOF-mediated synergistic cuproptosis and ferroptosis against malignancies.
Chen K; Zhou A; Zhou X; He J; Xu Y; Ning X
Sci Adv; 2024 Apr; 10(15):eadk3201. PubMed ID: 38598629
[TBL] [Abstract][Full Text] [Related]
12. Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials.
Wang J; Li J; Liu J; Chan KY; Lee HS; Lin KN; Wang CC; Lau TS
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339263
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial-Targeted Copper Delivery for Cuproptosis-Based Synergistic Cancer Therapy.
Deng J; Zhuang H; Shao S; Zeng X; Xue P; Bai T; Wang X; Shangguan S; Chen Y; Yan S; Huang W
Adv Healthc Mater; 2024 Mar; ():e2304522. PubMed ID: 38530073
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis.
Zhang P; Zhou C; Ren X; Jing Q; Gao Y; Yang C; Shen Y; Zhou Y; Hu W; Jin F; Xu H; Yu L; Liu Y; Tong X; Li Y; Wang Y; Du J
Redox Biol; 2024 Feb; 69():103007. PubMed ID: 38150993
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]